Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Natural Alternatives International

This article was originally published in The Tan Sheet

Executive Summary

New products from a joint venture with FitnessAge Inc. are expected to roll out in the second half of 2000, NAI says. The San Marcos, Calif.-based contract manufacturer must make an initial capital contribution of $100,000 toward Custom Nutrition, a new entity that will develop and distribute customized supplements and related products through health and fitness clubs, certified personal trainers and over the Internet. Income, losses and any additional capital contribution requirements for Custom Nutrition will be allocated 60% to FitnessAge, 40% to NAI. The FitnessAge deal is one of several diversification initiatives NAI has undertaken to partially counteract the loss of NuSkin Enterprises as a major customer in the fiscal 2000 second quarter ended Dec. 31. The loss of NuSkin, which comprised about 37% of net sales for the same period the year before, primarily accounted for a 30.3% decrease in sales to $12.1 mil. for the recent quarter

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090905

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel